Profil
Steve Colletti is currently the Chief Scientific Officer at Korro Bio, Inc. He previously worked as the SVP-Drug Discovery Research & Development at Zymergen, Inc. from 2021 to 2023.
Before that, he was the Chief Scientific Officer at Lodo Therapeutics Corp.
from 2018 to 2021.
Dr. Colletti holds a doctorate degree from Boston University and an undergraduate degree from Loyola University of Chicago.
Aktiva positioner av Steve Colletti
| Företag | Position | Start |
|---|---|---|
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Teknisk/Vetenskaplig/F&U Direktör | 2023-02-01 |
Tidigare kända positioner av Steve Colletti
| Företag | Position | Slut |
|---|---|---|
| ZYMERGEN INC. | Företagsledare/Principal | 2023-01-01 |
Lodo Therapeutics Corp.
Lodo Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel therapeutics | Teknisk/Vetenskaplig/F&U Direktör | 2021-05-01 |
Steve Collettis utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University of Chicago
Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymergen, Inc.
Zymergen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that designs and develops genomics products | Health Technology |
Lodo Therapeutics Corp.
Lodo Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel therapeutics | Health Technology |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
















